Angola vs China, Macao Special Administrative Region: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Angola
3.1%
in 2024
China, Macao Special Administrative Region
0.1%
in 2024
Angola rank
5th
China, Macao Special Administrative Region rank
2nd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Angola
- China, Macao Special Administrative Region
How they compare
Angola currently reports 3.1% against 0.1% in China, Macao Special Administrative Region, a difference of 3.0%.
That makes Angola's figure about 31.0 times China, Macao Special Administrative Region's.
Across all 10 years both countries report, Angola has been ahead every year.
Angola ranks 5th and China, Macao Special Administrative Region ranks 2nd of 246 countries.
Angola has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Angola | China, Macao Special Administrative Region | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.6% | 0.2% | 2.5% | Angola |
| 2020s | 3.0% | 0.1% | 2.9% | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Angola or China, Macao Special Administrative Region?
- Angola, at 3.1% against 0.1% in China, Macao Special Administrative Region as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Angola and China, Macao Special Administrative Region?
- 3.0%, with Angola ahead.
- How many years of comparable data are there for Angola and China, Macao Special Administrative Region?
- 10 years are reported by both, from 2015 to 2024.
- How do Angola and China, Macao Special Administrative Region rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Angola ranks 5th and China, Macao Special Administrative Region ranks 2nd of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.